| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
About This CME Activity
|
|
|
2009
|
6 |
12 |
p. 571-
1 p.
|
artikel
|
| 2 |
A community oncology quality initiative: guideline adherence with adjuvant hormonal therapy in women ≥ age 45 with stages IB-IIIC hormone-sensitive breast cancer
|
Bosserman, Linda D.
|
|
2009
|
6 |
12 |
p. 551-557
7 p.
|
artikel
|
| 3 |
Compliance with adjuvant radiotherapy after surgery for primary breast cancer
|
Deutsch, Melvin
|
|
2009
|
6 |
12 |
p. 547-550
4 p.
|
artikel
|
| 4 |
ITP in Elderly Patients: Practicing With S. Gerald Sandler, MD
|
|
|
2009
|
6 |
12 |
p. 571-572
2 p.
|
artikel
|
| 5 |
Measures of disease frequency and mortality
|
Streiner, David L.
|
|
2009
|
6 |
12 |
p. 573-575
3 p.
|
artikel
|
| 6 |
Rational care is not rationing
|
Bosserman, Linda D.
|
|
2009
|
6 |
12 |
p. 536-
1 p.
|
artikel
|
| 7 |
Should the NCI worry about community research?
|
Young, Patrick
|
|
2009
|
6 |
12 |
p. 581-582
2 p.
|
artikel
|
| 8 |
The health-care debate betrays our heritage
|
Follansbee, William P.
|
|
2009
|
6 |
12 |
p. 540-541
2 p.
|
artikel
|
| 9 |
The role of community oncologists in the prevention and treatment of VTE: clinical guidelines and CMS payment policy
|
Goldsmith, Myron
|
|
2009
|
6 |
12 |
p. 563-568
6 p.
|
artikel
|
| 10 |
Trastuzumab in HER2-positive advanced esophagogastric adenocarcinoma
|
Abraham, Jame
|
|
2009
|
6 |
12 |
p. 543-544
2 p.
|
artikel
|
| 11 |
VTE: still undertreated and ‘underprevented’
|
Gould, Randi Londer
|
|
2009
|
6 |
12 |
p. 569-
1 p.
|
artikel
|
| 12 |
Welcome to the team: trastuzumab in HER2-positive esophagogastric cancers
|
George Jr., Thomas J.
|
|
2009
|
6 |
12 |
p. 544-545
2 p.
|
artikel
|
Tijdschrift beschrijving